VISION
Inspiring transformational change in the
field of oncology diagnostics
MISSION
To develop and deliver accurate, rapid, minimally
invasive oncology diagnostic products utilising our
patented MCM5 antibodies
Arquer Diagnostics is focused on the development and commercialisation of highly accurate minichromosome maintenance (MCM) protein based non-invasive tests for cancer diagnosis and monitoring.
Arquer aim to meet demand expressed by patients, clinicians and payers for cost-effective healthcare technologies that not only enhance patient care but help to reduce overall healthcare costs by improving patient outcomes.
Arquer aim to meet demand expressed by patients, clinicians and payers for cost-effective healthcare technologies that not only enhance patient care but help to reduce overall healthcare costs by improving patient outcomes.
Latest News
Arquer Diagnostics @Arquer Diagnostics
Hello #Venice! #Arquer Diagnostics and #Pantec SRL are in attendance at the 92nd Annual Italian #Urology Congress.
https://t.co/FhOvCtBxtO https://t.co/XCqoUQcLMt
Arquer Diagnostics @Arquer Diagnostics
99.5% is the measure of the ability of our #ADXBLADDER technology to exclude the presence of a bladder cancer tumour (excl. non LGpTa). Find out more about how we're helping #urology and #cancerpatients worldwide: https://t.co/FhOvCtBxtO
#Arquer https://t.co/za2WQF270r
Arquer Diagnostics @Arquer Diagnostics
If a #patient refuses a #cystoscopy, there are other options. Our #ADXBLADDER can exclude the presence of #bladdercancer (99.5% NPV for non LGpTa #tumours), without unpleasant testing.
https://t.co/FhOvCtBxtO https://t.co/t7oBWgHsuY
Arquer Diagnostics @Arquer Diagnostics
856 patients were enrolled in our multicentre #clinicalstudy of #ADXBLADDER, which can exclude the presence of non-LGpTa #bladdercancer tumours in 98.9% of cases.
#Arquer #ArquerDX #ADXBLADDER #ArquerDiagnostics #health https://t.co/IyWWxYcEm8
Arquer Diagnostics @Arquer Diagnostics
With the ability to accurately rule out high-grade #tumours in 98.9% of cases, #ADXBLADDER could replace cytology, offering premium #diagnostic solutions to #urologists and patients alike.
#Arquer #ArquerDX #ADXBLADDER #ArquerDiagnostics #health https://t.co/Y4m8v548yY
